m+Medelevator.RU
← Поиск публикаций
Advances in radiation oncology · 2026

Comparative Outcomes of Single- and Split-Fraction Low-Dose Radiation in Mycosis Fungoides.

СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Lange Sarah J, Trepanowski Nicole, Ajmani Ayushya, Gonzalez Sarah M, Xia Xiaoqing, Lansigan Frederick, Carter Joi B, Jarvis Lesley A

Аннотация

PURPOSE: Localized radiation is a cornerstone therapy for early-stage mycosis fungoides (MF), with low-dose regimens achieving high response rates. However, the optimal fractionation schedule remains unclear. Single-fraction (8 Gy × 1) and split-fraction (4 Gy × 2) regimens are widely used, but comparative data are limited. Reducing treatment burden may be particularly important in rural settings, where travel distance can limit access.

METHODS AND MATERIALS: This study aims to compare lesion-level response, recurrence, and durability between 8 Gy × 1 and 4 Gy × 2 low-dose radiation regimens in MF. We performed a retrospective review of 136 lesions from 27 adults with biopsy-confirmed MF treated with localized electron beam radiation at a rural multidisciplinary cutaneous lymphoma clinic (2014-2025). Lesions were categorized as patch or plaque. The primary outcome was complete response (CR) at 6 months. Secondary outcomes included overall response rate, local recurrence, time to next therapy, and toxicity. Analyses included χ²/Fisher's exact tests, Kaplan-Meier survival, Cox regression, and inverse-probability weighting.

RESULTS: Of 136 lesions, 119 (87.5%) received 4 Gy × 2 and 17 (12.5%) received 8 Gy × 1. Six-month CR was 81.5% versus 82.4%, respectively (P = 1.0). Overall response rate was 98.3% versus 100%, respectively (P = 1.0). Six-month local recurrence occurred in 3.4% versus 11.8% of lesions (P = .17), and additional local treatment within 6 months was required in 12.6% versus 5.9% of lesions (P = .69). No grade ≥2 toxicities occurred. Median patient travel distance was 86.2 miles versus 71.0 miles (P = .069). Multivariable and inverse-probability weighting analyses showed no association between regimen and CR at 6 months.

CONCLUSIONS: Limitations of this study include retrospective design and small single-fraction sample. Single-fraction 8 Gy was associated with similar short-term outcomes and excellent tolerability, supporting its use as an effective, logistically advantageous option, particularly in rural practice.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты